Treatment with a monoclonal LOXL2 antibody (AB0024) in murine models of liver and lung fibrosis resulted in amelioration of histological fibrosis scores, substantial reduction in collagen and αSMA positive fibroblasts13. The gene discussed is ACTA1; the disease is pulmonary fibrosis.